Status:
ACTIVE_NOT_RECRUITING
The Use of Ultrasound Detection of Lipohypertrophy to Improve Glycemic Control
Lead Sponsor:
University of British Columbia
Conditions:
Diabetes Mellitus
Lipohypertrophy
Eligibility:
All Genders
19-80 years
Phase:
NA
Brief Summary
Lipohypertrophy is swelling of the fatty tissue located below the skin ("subcutaneous tissue") where many patients with diabetes inject their insulin. Lipohypertrophy can sometimes be felt as firm swe...
Detailed Description
Purpose: In Phase 1: to use computer based technology to detect lipohypertrophy on portable ultrasound images. In Phase 2: to demonstrate that injecting insulin into areas to be free of lipohypertro...
Eligibility Criteria
Inclusion
- Subjects with a diagnosis of Type 1 or Type 2 diabetes mellitus
- Current treatment with a minimum of one insulin injection daily or insulin pump for at least 2 years
Exclusion
- Subjects taking a glucagon-like peptide-1 agonist or a systemic glucocorticoid
- Past history of a non-lipohypertrophic dermatological condition in the insulin injection site area
Key Trial Info
Start Date :
March 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05377268
Start Date
March 1 2023
End Date
December 31 2025
Last Update
May 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vancouver General Hospital Diabetes Centre
Vancouver, British Columbia, Canada, V5Z 1M9